Hematological Diseases and Therapies
ISSN: 2577-1418
Impact Factor: 3.02
research article
Role of miR_155a and miR_181a in Chronic Lymphocytic Leukemia
Nashwa EL-Khazragy*, Mohamed Hosny, Mostafa M Elhady, Ahmed El-Agmawy, Nahla S Hassan
Hematological Diseases and Therapiesresearch article
Which Factor Is Responsible forThe Prognosis in Myelodysplastic Syndrome Patients with an Isolated Del(5q) or A Cytogenetic Abnormality in Addition to Del(5q): Blast Counts or Cytogenetics?
Hava ÜSKÜDAR TEKE*, Neslihan ANDIÇ, Tuba KİRAZ BULDUK, Eren GÜNDÜZ, Muzaffer BİLGİN, Olga Meltem AKAY, Beyhan DURAK ARAS
Hematological Diseases and Therapiesresearch article
Toxicities and Long Term Survival After Autologous Hematopoietic Stem Cell Transplantation for Older Patients with Relapsed/Refractory Hodgkin Lymphoma
Gunjan L Shah*, Connie Lee, Hillary Glick, Satyajit Kosuri, Sean M Devlin, Joachim Yahalom, Parastoo Dahi, Paul Hamlin, Alison Moskowitz, David J Straus, Sergio A Giralt, Craig S Sauter, Craig H Moskowitz, Matthew J Matasar
Hematological Diseases and Therapies